Seize the New Opportunity of Biomedical Industry Development Shanghai Releases Three Frontier Track Action Plans

On October 16, the opening activity of 2023 Shanghai International Biomedical Industry Week ("Industry Week" for short) was held in Shanghai. At the opening activity of the Industry Week, Shanghai released three action plans for the three frontier tracks of synthetic biology, gene therapy and medical robots. Shanghai will continue to focus on the key frontier innovation track of biomedicine, plan and layout in advance, and accelerate the construction of a globally influential innovation highland of biomedicine industry and a world-class biomedicine industry cluster.

Building a world-class biomedical industry cluster

The theme of this industry week is "mutual help for the future, full of vitality". The reporter of China Securities News learned from the opening ceremony that Shanghai officially released the action plans for three cutting-edge tracks, namely synthetic biology, gene therapy and medical robots, as well as the action plan for the construction of intelligent manufacturing space for biomedicine, to strengthen the function of scientific and technological innovation as a source of policy, and to support Shanghai's biomedicine industry to expand space and release productivity.

The Action Plan for Shanghai to Accelerate the Innovation of Synthetic Biotechnology and Build a High end Bio manufacturing Industrial Cluster (2023-2025) proposes to seize the new wave of global bio economic reform and take synthetic biotechnology as an important engine for the development of Shanghai's high-end manufacturing industry; The Action Plan of Shanghai for Promoting the Scientific and Technological Innovation and Industrial Development of Gene Therapy (2023-2025) is committed to breaking through the key core technology of gene therapy, improving clinical research and transformation capacity, promoting the progress of production technology, optimizing the ecological development of industry, and comprehensively improving the innovative policy capacity and industrial development level of gene therapy technology in Shanghai; The Action Plan of Shanghai for Promoting the Development of Medical Robot Industry (2023-2025) aims to form an innovative system of industry and medicine integration, digital intelligence driven and open leading, and create a batch of domestic and even international advanced innovative medical robot products.

In order to show the overall situation of the digital transformation of the biomedical industry, the 2023 Global Biomedical Industry Digital Transformation Ecological Map was officially released, which systematically outlines the overall picture of the digital transformation of the biomedical industry and shows some representative enterprises of six core applications, four industrial platforms and six key technologies.

It is reported that Shanghai will continue to focus on the key frontier innovation track of biomedicine, plan and layout in advance, and accelerate the construction of a globally influential innovation highland of biomedicine industry and a world-class biomedicine industry cluster.

Global cooperation moves quickly and steadily

At the opening ceremony, the "Shanghai Innovative Medicine and Equipment Sailing International Partner Sailing Ceremony" was held. This is one part of a package of overseas assistance programs elaborately created by Shanghai for local innovative enterprises. It guides enterprises to achieve complementary advantages at the R&D end, leads domestic biomedical enterprises to open overseas markets at the sales end, and builds a network of overseas partners.

"Through leading innovative pharmaceutical enterprises, we can link global industry, university and research resources, create an international platform with a global perspective, explore global innovation targets, and promote industrial transformation and upgrading." Xie Qirun, chairman of the board of directors of China Biopharmaceutical Co., Ltd., said.

Gu Yushao, global senior vice president of Medtronic and president of Greater China, suggested that we should make good use of Shanghai's comprehensive advantages such as openness and innovation, talent gathering, and clinical research, continue to deepen cooperation with large pharmaceutical companies in Shanghai in terms of cultivating start-ups, promoting medical research and development, and help Shanghai build a world-class biomedical industry cluster with mature global resources.

key word: Biomedicine Shanghai industry gene therapy